Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis
AUTOR(ES)
Hettema, M E
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1994313Documentos Relacionados
- Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
- Selection of vasodilator therapy for severe Raynaud's phenomenon by sequential arterial infusion.
- Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis.
- A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.
- Systemic lupus erythematosus and Raynaud's phenomenon